— Know what they know.
Not Investment Advice

KROS NASDAQ

Keros Therapeutics, Inc.
1W: +2.1% 1M: -1.9% 3M: -30.7% YTD: -39.5% 1Y: -20.6% 3Y: -75.8% 5Y: -77.0%
$11.19
-0.03 (-0.27%)
 
Weekly Expected Move ±6.9%
$9 $10 $10 $11 $12
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 36 · $358.1M mcap · 30M float · 1.46% daily turnover · Short 60% of daily vol
Last Earnings 2026-05-14
EPS
$-1.21
▼ Miss -31.5%
Revenue
$367K
▼ Miss -81.0%
Next Earnings 2026-08-12
EPS Estimate
$-1.43
Range: $-2.07 - $-1.05
Revenue Estimate
$807K
4 analysts

Estimate vs Actual

Earnings Surprise History

11/19
EPS Beats
3/19
Revenue Beats
58%
EPS Beat Rate
16%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-22 quarter 2026-09-30 $-1.57 $-1.61 ▼ 0.04 $685,714 $664,286
2026-05-22 annual 2028-12-31 $-3.95 $-4.07 ▼ 0.12 $58,118,429 $56,451,857
2026-05-22 annual 2026-12-31 $-5.98 $-6.14 ▼ 0.16 $3,952,429 $3,869,143
2026-05-22 annual 2029-12-31 $-3.92 $-4.07 ▼ 0.15 $74,038,714 $70,988,143
2026-05-22 annual 2027-12-31 $-5.78 $-5.89 ▼ 0.11 $13,665,167 $11,884,429
2026-05-22 quarter 2026-06-30 $-1.39 $-1.43 ▼ 0.04 $828,571 $807,143
2026-05-22 quarter 2026-12-31 $-1.87 $-1.91 ▼ 0.04 $800,000 $778,571
2026-05-22 annual 2030-12-31 $-2.27 $-2.37 ▼ 0.11 $114,881,833 $111,029,167
2026-05-18 quarter 2028-12-31 $-1.02 $-2.29 ▼ 1.27 $751,953 $677,904
2026-05-18 quarter 2027-03-31 $-1.04 $-1.48 ▼ 0.44 $10,000,000 $433,333
2026-05-18 annual 2030-12-31 $-2.55 $-2.27 ▲ 0.29 $86,835,333 $114,881,833
2026-05-18 quarter 2026-12-31 $-1.35 $-1.87 ▼ 0.52 $500,000 $800,000
2026-05-18 quarter 2028-03-31 $-1.01 $-2.18 ▼ 1.17 $636,074 $573,437
2026-05-18 quarter 2026-09-30 $-1.22 $-1.57 ▼ 0.35 $500,000 $685,714
2026-05-18 annual 2026-12-31 $-5.77 $-5.98 ▼ 0.21 $4,338,143 $3,952,429
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms